Potassium canrenoate
CAS No. 2181-04-6
Potassium canrenoate( Canrenoate potassium | SC 14266 | SC-14266 )
Catalog No. M17721 CAS No. 2181-04-6
Potassium canrenoate is a synthetic pregnadiene derivative with anti-aldosterone activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 26 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePotassium canrenoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionPotassium canrenoate is a synthetic pregnadiene derivative with anti-aldosterone activity.
-
DescriptionCanrenoate potassium is a synthetic pregnadiene derivative with anti-aldosterone activity.(In Vivo):Potassium canrenoate has been shown to cause in rats a dose-dependent increase in myelogenous leukemia and statistically significant increases in malignant tumor of the liver, thyroid, brain and mammary gland.Potassium canrenoate (20 mg/kg/day; drinking water) reduces isoprenaline-induced cardiac fibrosis in the rat.
-
In Vitro——
-
In VivoPotassium canrenoate has been shown to cause in rats a dose-dependent increase in myelogenous leukemia and statistically significant increases in malignant tumor of the liver, thyroid, brain and mammary gland.Potassium canrenoate (20 mg/kg/day; drinking water) reduces isoprenaline-induced cardiac fibrosis in the rat.
-
SynonymsCanrenoate potassium | SC 14266 | SC-14266
-
PathwayGPCR/G Protein
-
TargetS1P Receptor
-
RecptorMineralocorticoid Receptor
-
Research AreaEndocrinology
-
Indication——
Chemical Information
-
CAS Number2181-04-6
-
Formula Weight396.56
-
Molecular FormulaC22H29KO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 100 mg/mL (252.17 mM)
-
SMILES[K+].C(=O)(CC[C@@]1(CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4([C@H]3CC[C@]12C)C)O)[O-]
-
Chemical Name17-alpha-Pregna-4,6-diene-21-carboxylic acid, 17-hydroxy-3-oxo-, monopotassium salt
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alexandre J, et al. J Cardiovasc Pharmacol Ther. 2015 May;20(3):313-21.
molnova catalog
related products
-
JTE-013
JTE-013 is an effective and specific antagonist of S1P2. JTE-013 suppresses the specific binding of radiolabeled S1P to human and rat S1P2 (IC50s: 17 nM and 22 nM, respectively).JTE-013 is a S1P2 antagonist. JTE-013 (50-200 μM;?1-3 days) decreased cell viability.
-
Complanatoside A
Complanatoside A is a flavonol glycoside isolated from Astragalus complanatus.
-
SK1-IN-1
SK1-IN-1 is an orally available and potent sphingosine kinase 1 (SPHK1) inhibitor (IC50: 58 nM), with potential anticancer activity, and can be used to study cancer and neurodegenerative diseases.
Cart
sales@molnova.com